Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk-Reference-Cited by-同舟云学术

Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk

Published:1999-03 Issue:2 Volume:5 Page:101-105
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

THORLAND E. C.¹,DROST J. B.²,LUSHER J. M.³,WARRIER I.³,SHAPIRO A.⁴,KOERPER M. A.⁵,DIMICHELE D.⁶,WESTMAN J.⁷,KEY N. S.⁸,SOMMER S. S.¹²

Affiliation:

1. Department of Biochemistry and Molecular Biology, Mayo Clinic/Foundation, Rochester, MN, USA,

2. City of Hope, Duarte, CA, USA,

3. Children's Hospital of Michigan, Detroit, MI, USA

4. Riley Hospital, Indianapolis, IN, USA

5. Department of Paediatrics, UCSF Medical Center, San Francisco, CA, USA,

6. New York Hospital‐Cornell Medical Center, Hemophilia Treatment Center, New York, NY, USA,

7. Regional Genetics Center, Children's Hospital, Columbus, OH, USA,

8. University of Minnesota Hospital and Clinic, Comprehensive Hemophilia Center, Minneapolis, MN, USA

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2516.1999.t01-1-00303.x

Reference27 articles.

1. Factor IX inhibitors in haemophilia B patients: their incidence and prospects for development with high purity factor IX products;Briët E.;Blood Coagul Fibrinolysis,1991

2. Prevalence of inhibitors in a population of 3435 hemophilia patients in France;Sultan Y;Thromb Haemost,1992

3. Molecular biology of the hemophilias;Thompson AR.;Prog Hemost Thromb,1991

4. Prevalence of factor IX inhibitors among patients with haemophilia B: results of a large-scale North American survey

5. Gene deletions in patients with haemophilia B and anti-factor IX antibodies

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotype-phenotype analyses of Iranian patients with hemophilia B (Leyden -) and hemophilia B (Leyden +): A single-center study;Transfusion and Apheresis Science;2024-08

2. Pleiotropic effects of different exonic nucleotide changes at the same position contribute to hemophilia B phenotypic variation;Journal of Thrombosis and Haemostasis;2024-04

3. Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China;Haemophilia;2022-09-26

4. EFFICACY OF DESENSITIZATION THERAPY FOR ALLERGY TO FACTOR IX CONCENTRATES;Japanese Journal of Transfusion and Cell Therapy;2022-06-24

5. The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B;Haemophilia;2021-06-12